Twelve‑Month Response and Safety of Intravitreal Dexamethasone Implant in Treatment‑Naïve and Recalcitrant Diabetic Macular Edema (TREAT-DME Study)

Somnath Chakraborty, Jay U Sheth, Santanu Ganguly, Rahul Reddy · 2025

Read Twelve‑Month Response and Safety of Intravitreal Dexamethasone Implant in Treatment‑Naïve and Recalcitrant Diabetic Macular Edema (TREAT-DME Study) by Somnath Chakraborty, Jay U Sheth, Santanu Ganguly, Rahul Reddy (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12744596.txt.

Description

Somnath Chakraborty and co-authors followed 102 eyes in 2025 for a year after a slow release steroid implant was placed inside the eye to treat swelling at its center caused by diabetes. They compared eyes new to treatment with eyes where other therapies had failed.

Patients at two Indian centers got the implant and repeat doses when fluid returned or vision slipped. Vision improved modestly by twelve months in both groups, with no clear gap between them. The swollen center thinned substantially on scans. Stubborn eyes needed slightly more implants on average. Eye pressure rises and cataract growth were watched as the known risks. The authors judge the implant a fair option for both kinds of eyes.

Catalog record

CREATORSomnath Chakraborty, Jay U Sheth, Santanu Ganguly, Rahul Reddy
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12744596

Browse the full library · About the Tower of Babel